PrognosisMultivariate AnalysisRetrospective StudiesRisk FactorsSurvival AnalysisSurvival RateFollow-Up StudiesTreatment OutcomeTumor Markers, BiologicalNeoplasm StagingKaplan-Meier EstimateProportional Hazards ModelsProspective StudiesPredictive Value of TestsTime FactorsDisease-Free SurvivalCohort StudiesLogistic ModelsImmunohistochemistryBreast NeoplasmsAge FactorsLymphatic MetastasisRegression AnalysisDisease ProgressionNeoplasm Recurrence, LocalRisk AssessmentAdenocarcinomaRecurrenceCase-Control StudiesSeverity of Illness IndexNeoplasm InvasivenessCross-Sectional StudiesBiological MarkersGene Expression Regulation, NeoplasticLung NeoplasmsOdds RatioIncidenceCombined Modality TherapyAnalysis of VarianceChi-Square DistributionLiver NeoplasmsSex FactorsCarcinoma, Squamous CellPrevalenceNeoplasm MetastasisStomach NeoplasmsColorectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsTissue Array AnalysisQuestionnairesROC CurveCarcinoma, HepatocellularCarcinomaNeoplasm GradingUnited StatesJapanGene Expression ProfilingSensitivity and SpecificityBrain NeoplasmsCell Line, TumorEsophageal NeoplasmsReproducibility of ResultsInfant, NewbornTomography, X-Ray ComputedAcute DiseaseRiskMyocardial InfarctionKi-67 AntigenLinear ModelsChemotherapy, AdjuvantRegistriesComorbidityNeoplasm ProteinsReceptor, erbB-2Immunoenzyme TechniquesOvarian NeoplasmsModels, StatisticalSocioeconomic FactorsCarcinoma, Non-Small-Cell LungAntineoplastic AgentsLongitudinal StudiesPrincipal Component AnalysisPostoperative ComplicationsChinaHeart FailureReceptors, EstrogenEpidemiologic MethodsGenotypeMagnetic Resonance ImagingDiscriminant AnalysisNeoplasmsPancreatic NeoplasmsSmokingMelanomaChronic DiseaseConfidence IntervalsBiopsyKidney NeoplasmsReverse Transcriptase Polymerase Chain ReactionHospital Mortality